4CNC
Crystal structure of human 5T4 (Wnt-activated inhibitory factor 1, Trophoblast glycoprotein)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I02 |
Synchrotron site | Diamond |
Beamline | I02 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2013-04-26 |
Detector | DECTRIS PILATUS 6M |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 49.600, 95.820, 65.970 |
Unit cell angles | 90.00, 91.14, 90.00 |
Refinement procedure
Resolution | 54.330 - 1.770 |
R-factor | 0.17929 |
Rwork | 0.177 |
R-free | 0.21727 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5T4 CRYSTAL FORM WITH 1 MOLECULE IN THE ASYMMETRIC UNIT |
RMSD bond length | 0.016 |
RMSD bond angle | 1.905 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | REFMAC (5.7.0032) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 54.330 | 1.820 |
High resolution limit [Å] | 1.770 | 1.770 |
Rmerge | 0.060 | 0.760 |
Number of reflections | 59830 | |
<I/σ(I)> | 13.8 | 2.5 |
Completeness [%] | 99.7 | 99.5 |
Redundancy | 5 | 4.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | THE CRYSTALLIZATION SITTING DROP CONTAINED 100 NL OF CONCENTRATED 5T4/WAIF1 (5 MG/ML IN 20 MM TRIS-HCL, PH 7.5, 150 MM NACL) PLUS 100 NL OF 0.2 M (NH4)2SO4, 30 % W/V PEG 4000. |